Drug intelligence / Profile preview

PH-10

Development stage
Phase 2
Lead developer
Provectus Biopharmaceuticals
Modality
Classical Binding Small Molecules → Small Molecules, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

PH-10 is a topical hydrogel formulation developed by Provectus Pharmaceuticals, containing rose bengal disodium, a small molecule belonging to the class of halogenated xanthenes. It is designed for the treatment of inflammatory dermatoses such as atopic dermatitis and psoriasis. The drug functions by undergoing photochemical reactions when activated by ambient light, leading to the down-regulation and normalization of various disease-related genes, including IL-17A, IL-22, IL-26, IL-36, keratin 16, IL-23, S100A7, IL-19, and CXCL1, and modulating pathways involving IL-17, IL-22, and interferons, thereby ameliorating skin inflammation.

Brand names
Xantryl
Other names
rose bengal disodiumrose bengalRB
02

Targets

IL-17A (Interleukin-17A)IL22 (Interleukin 22)IL-23 (Interleukin-23)CXCL1 (C-X-C motif chemokine ligand 1)IL19 (Interleukin-19)IL26 (Interleukin-26)S100A9 (Myeloid-related protein 14)

Beyond the preview

Go deeper on PH-10.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PH-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call